Core Insights - *ST Lingda (300125.SZ) reported a significant increase in revenue for the first three quarters of 2025, reaching 89.09 million yuan, which represents a year-on-year growth of 83.47% [1] - The company recorded a net loss attributable to shareholders of 128 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 112 million yuan [1] - The basic loss per share was 0.478 yuan [1]

截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 公司名稱: 新興光學集團控股有限公司 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00125 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | HKD | | 0.1 | HKD | | 50,000,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 500,000,000 | HKD | | 0.1 | HKD | | 50,000,000 | 本月底法定/註冊股 ...

Core Viewpoint - The company received a regulatory attention letter from the Dalian Regulatory Bureau of the China Securities Regulatory Commission, highlighting insufficient impairment provisions for the Jinzhai Jiayue Phase I project and internal control deficiencies [1] Summary by Relevant Sections Impairment Issues - The company was found to have inadequately recognized impairment for the Jinzhai Jiayue Phase I project, with a reported impairment of 218 million yuan as per an assessment by Chongqing Henghe Asset Appraisal Co., Ltd. This impairment primarily concerns P-type equipment, while general equipment was not subjected to impairment [1] Internal Control Deficiencies - The Dalian Regulatory Bureau noted that the company's internal control systems were not properly executed. Issues included the lack of approval for certain procurement, loan contracts, and external guarantees. Additionally, there were instances of labor dispatch employees receiving wages on behalf of others or for severance payments [1] Board Meeting and Agreements - On May 3, 2023, the company held its sixth board meeting, where it approved a targeted issuance proposal and signed an investment agreement for a high-efficiency photovoltaic cell project with the Tongling Shizishan High-tech Zone Management Committee. These matters were not registered for insider information [1]

Core Viewpoint - *ST Lingda (300125.SZ) has disclosed that its director, Mr. Bai Jianghong, has been restricted from consumption due to a legal dispute involving a contract worth approximately RMB 7.21 million [1] Company Summary - The restriction on the director is linked to a court ruling regarding a contract dispute between Zhongheng Zhuochuang (Chongqing) Engineering Design Co., Ltd., where Mr. Bai serves as the legal representative, and China New Era Construction Engineering Co., Ltd. [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00125 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | HKD | | 0.1 HKD | | 50,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 500,000,000 | HKD | | 0.1 HKD | | 50,000,000 | 本月底法定/註冊股本總額： HKD 50,000,000 FF301 第 1 頁 共 10 頁 v 1.1.1 公司名稱: 新 ...

香港联交所最新资料显示，8月15日，FIDELITY PURITAN TRUST减持新兴光学(00125)77.2万股，每股 作价0.4港元，总金额为30.88万港元。减持后最新持股数目约为1513.02万股，最新持股比例为5.76%。 ...

Group 1 - Fidelity Puritan Trust reduced its holdings in Emerging Optical (00125) by 772,000 shares at a price of HKD 0.4 per share, totaling HKD 308,800 [1] - After the reduction, Fidelity Puritan Trust's latest shareholding is approximately 15.13 million shares, representing a holding percentage of 5.76% [1]

Group 1 - FMR LLC reduced its stake in Emerging Optical (00125) by 860,000 shares at a price of HKD 0.4138 per share, totaling approximately HKD 355,900 [1] - After the reduction, FMR LLC's remaining shareholding is approximately 20.616 million shares, representing a holding percentage of 7.85% [1]

Group 1 - FMR LLC reduced its stake in Emerging Optical (00125) by 860,000 shares at a price of HKD 0.4138 per share, totaling approximately HKD 355,900 [1] - After the reduction, FMR LLC's remaining shareholding is approximately 20.616 million shares, representing a holding percentage of 7.85% [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致 的任何損失承擔任何責任。 於股東週年大會舉行日期，本公司之已發行股份（「股份」）總數為 262,778,286 股，此乃賦 予其持有人權利出席股東週年大會並於會上投票贊成或反對決議案之股份總數。此外，概 無股份賦予其持有人權利出席股東週年大會及需根據香港聯合交易所有限公司證券上市規 則（「上市規則」）第 13.40 條放棄表決贊成的權利。股東於股東週年大會上就任何決議案投 票均不受任何限制，並無股東需根據上市規則的要求放棄表決贊成的權利。 本公司之香港股份過戶處聯合證券登記有限公司獲委任為監票人，負責股東週年大會之點 票工作。以下為於股東週年大會上投票贊成及反對個別決議案之股份數目： | | | 出席及投票 | 票數(%) | | | --- | --- | --- | --- | --- | | | | （親自或其 委代表） | | | | | 普通決議案 | | 贊成 | 反對 | | 1. | 省覽、考慮及採納截至二零二五 ...